Development and Validation of a Metastatic Breast Cancer-Specific Prognostic Model Using CancerLinQ Discovery.
An electronic health record-based prognostic model is developed to identify patients with metastatic breast cancer at high risk of near-term death and can predict risk of death within 30 and 90 days for patients with MBC.